Literature DB >> 24398373

Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, The Netherlands.

C Richter1, G Ter Beest1, E H Gisolf1, P VAN Bentum1, C Waegemaekers2, C Swanink3, E Roovers4.   

Abstract

Migrants born in hepatitis B virus (HBV) and hepatitis C virus (HCV) endemic countries are at increased risk of being infected with these viruses. The first symptoms may arise when liver damage has already occurred. The challenge is to identify these infections early, since effective treatment has become available. In 2011 we conducted a screening project in first-generation migrants (FGMs) born in Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam and living in Arnhem and Rheden. All participants were offered free blood screening for HBV and HCV. In total 959 participants were tested, with the country of origin known for 927, equating to 28·7% of all registered FGMs from the chosen countries. Nineteen percent (n = 176) had serological signs of past or chronic HBV infection and 2·2% (n = 21) had chronic HBV infection. The highest prevalence of chronic HBV infection was found in the Vietnamese population (9·5%, n = 12). Chronic HCV was found in two persons from the former Soviet Republics and one from Vietnam. Twenty-four percent (n = 5) of the newly identified patients with chronic HBV and one of the three patients with chronic HCV received treatment. Three of the patients, two with HCV and one with HBV, already had liver cirrhosis. The highest (9·5%) HBV prevalence was found in FGMs from Vietnam, indicating a high need for focusing on that particular immigrant population in order to identify more people with silent HBV infection. The fact that three patients already had liver cirrhosis underlines the necessity of early identification of HBV and HCV infection in risk groups.

Entities:  

Mesh:

Year:  2014        PMID: 24398373      PMCID: PMC9151278          DOI: 10.1017/S0950268813003415

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  20 in total

1.  Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.

Authors:  S J M Hahné; H E De Melker; M Kretzschmar; L Mollema; F R Van Der Klis; M A B Van Der Sande; H J Boot
Journal:  Epidemiol Infect       Date:  2011-11-14       Impact factor: 2.451

2.  High impact of migration on the prevalence of chronic hepatitis B in the Netherlands.

Authors:  Tanja Marschall; Mirjam Kretzschmar; Marie-Josee J Mangen; Solko Schalm
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-12       Impact factor: 2.566

3.  Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey.

Authors:  M Chironna; C Germinario; P L Lopalco; F Carrozzini; S Barbuti; M Quarto
Journal:  Infection       Date:  2003-03       Impact factor: 3.553

4.  Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?

Authors:  Anouk T Urbanus; Thijs J W van de Laar; Anneke van den Hoek; Freke R Zuure; Adrianus G C L Speksnijder; Gijs G G Baaten; Titia Heijman; Henrike J Vriend; Eline L M Op de Coul; Roel A Coutinho; Maria Prins
Journal:  J Hepatol       Date:  2011-04-13       Impact factor: 25.083

Review 5.  Hepatitis B infection in Vietnam: current issues and future challenges.

Authors:  Van T T Nguyen
Journal:  Asia Pac J Public Health       Date:  2010-12-15       Impact factor: 1.399

6.  [Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions].

Authors:  F D H Koedijk; E L M op de Coul; H J Boot; M J W van de Laar
Journal:  Ned Tijdschr Geneeskd       Date:  2007-10-27

7.  Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.

Authors:  Irene K Veldhuijzen; Mehlika Toy; Susan J M Hahné; G Ardine De Wit; Solko W Schalm; Robert A de Man; Jan Hendrik Richardus
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

8.  High prevalence of hepatitis C virus infection among immigrants from the former Soviet Union in the New York City metropolitan area: results of a community-based screening program.

Authors:  Steven Batash; Inessa Khaykis; Robert F Raicht; Edmund J Bini
Journal:  Am J Gastroenterol       Date:  2008-04       Impact factor: 10.864

Review 9.  Share of Afghanistan populace in hepatitis B and hepatitis C infection's pool: is it worthwhile?

Authors:  Sanaullah Khan; Sobia Attaullah
Journal:  Virol J       Date:  2011-05-11       Impact factor: 4.099

10.  Seroepidemiology of HBV infection in South-East of iran; a population based study.

Authors:  M Salehi; S M Alavian; S V Tabatabaei; Sh Izadi; E Sanei Moghaddam; S Amini Kafi-Abad; A Gharehbaghian; S Khosravi; H Abolghasemi
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

View more
  18 in total

1.  Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing.

Authors:  Jeanne Heil; Christian J P A Hoebe; Jochen W L Cals; Henriëtte L G Ter Waarbeek; Inge H M van Loo; Nicole H T M Dukers-Muijrers
Journal:  Ann Fam Med       Date:  2018-01       Impact factor: 5.166

Review 2.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Authors:  Daniele Mipatrini; Paola Stefanelli; Santino Severoni; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2017-02-06       Impact factor: 2.894

3.  Effectiveness of Interventions for Hepatitis B and C: A Systematic Review of Vaccination, Screening, Health Promotion and Linkage to Care Within Higher Income Countries.

Authors:  Elizabeth Ortiz; Brighid Scanlon; Amy Mullens; Jo Durham
Journal:  J Community Health       Date:  2020-02

Review 4.  Hepatitis B virus infection in immigrant populations.

Authors:  Nicola Coppola; Loredana Alessio; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Rosa Zampino; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-12-28

Review 5.  The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis.

Authors:  Hiam Chemaitelly; Karima Chaabna; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

6.  Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries.

Authors:  Amena A Ahmad; Abby M Falla; Erika Duffell; Teymur Noori; Angela Bechini; Ralf Reintjes; Irene K Veldhuijzen
Journal:  BMC Infect Dis       Date:  2018-01-11       Impact factor: 3.090

Review 7.  Current challenges and possible solutions to improve access to care and treatment for hepatitis C infection in Vietnam: a systematic review.

Authors:  Alessandra Berto; Jeremy Day; Nguyen Van Vinh Chau; Guy E Thwaites; Ngoc Nghiem My; Stephen Baker; Thomas C Darton
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

8.  Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015.

Authors:  Janneke P Bil; Peter Ag Schrooders; Maria Prins; Peter M Kouw; Judith He Klomp; Maarten Scholing; Lutje Phm Huijbregts; Gerard Jb Sonder; Toos Chfm Waegemaekers; Henry Jc de Vries; Wieneke Meijer; Freke R Zuure; Alma Tostmann
Journal:  Euro Surveill       Date:  2018-03

9.  Screening for Infectious Diseases among Newly Arrived Migrants: Experiences and Practices in Non-EU Countries of the Mediterranean Basin and Black Sea.

Authors:  Christian Napoli; Maria Grazia Dente; Tommi Kärki; Flavia Riccardo; Pasqualino Rossi; Silvia Declich
Journal:  Int J Environ Res Public Health       Date:  2015-12-08       Impact factor: 3.390

10.  Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.

Authors:  A M Falla; A A Ahmad; E Duffell; T Noori; I K Veldhuijzen
Journal:  BMC Infect Dis       Date:  2018-01-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.